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INTRODUCTION AND OBJECTIVES: 
Osteosarcoma (OS) is an aggressive 
malignancy that is the most common primary 
bone tumor in children. Nonsteroidal anti-
inflammatory drugs (NSAIDs) are widely 
used in orthopaedic surgery to reduce pain 
and inflammation. NSAIDs have been shown 
to be toxic to certain malignancies such as 
colorectal, breast, and pancreatic cancers, as 
well as acute myeloid leukemia, but are not 
well-studied in OS. The purpose of this study 
is to assess whether ketorolac and 
indomethacin induce apoptosis in OS cells, 
compare this to a control and explore the 
underlying mechanism. 
 
METHODS: A rat OS cell line (UMR-108) 
was exposed to various concentrations of 
both ketorolac and indomethacin. Both 
ketorolac and indomethacin were compared 
to a pH buffered saline control. The 
background death rate of the control was 
subtracted from the test samples. Cell 
viability, cytotoxicity, apoptosis induction, 
DNA fragmentation and the expression of 
apoptosis-related markers were examined by 
MTT assay, colony formation assay, flow 
cytometry, agarose gel electrophoresis, and 
western blot respectively. 
 
RESULTS: The results demonstrate that 
ketorolac and indomethacin induce apoptosis 
of rat OS cells in a dose-and time-dependent 
manner. Apoptosis was confirmed by cell 
morphology and annexin positivity. Both 
NSAIDs induced morphological changes in 
OS cells and decreased their capacity to form 
colonies. The molecular data showed that the 
NSAIDs affected expression of Bcl-2, 
survivin, and PARP. Caspase-3 was also 
decreased as shown in Figure 1. 
 
CONCLUSIONS: This study showed that 
both ketorolac and indomethacin caused a 
decrease in OS cell viability and an increase 
in apoptosis in a time-and dose-dependent 
matter. NSAIDs are well-studied, 
inexpensive and readily available with well 
known side effect profiles. Due to these 
characteristics, additional in vitro and in vivo 
research studies are warranted to identify the 
use of these medications in the treatment of 
OS in the clinical setting. 
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Figure 1. Expression of apoptotic proteins in 
OS tumor cells after being exposed to 
NSAIDs. UMR-108 cell were exposed to A1) 
1.78 and 3.75 mg of ketorolac for 48 hr, A2) 
0.125, 0.250 and 1 mg of indomethacin for 48 
hrand A3) 0.125, 0.250 for 72 hr. B) Cell 
were exposed to 0.93,1.78 and 3.75 mg of 
ketorolac and 0.062, 0.125 and 0.250 mg of 
indomethacin for 72 hr. Then total protein 
was isolated. Equal amounts of protein from 
each sample were loaded and separated 
through 12% SDS-PAGE gels and then 
transferred to PVDF membranes. The 
following antibodies were used; PARP, 
caspase-3, Bcl-2, survivin, and beta-actin. 
The bands were visualized by enhanced 
chemiluminescencekit instructions. Data 
were normalized to corresponding values of 
Beta-actin densitometry. (***p<0.001, ** 
p< 0.01). 
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